Identification of the reactive sulphydryl group of mitochondrial aspartate aminotransferase from pig heart.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to G Stanway.
Explore the source record for details and available documents.
A new genus of the family Picornaviridae, Parechovirus, has recently been recognised on the basis of distinctive biological and molecular properties. In particular: parechoviruses exhibit characteristic effects on the host cell; cleavage of the capsid protein VP0, required for maturation of the virus particle in most other picornaviruses, does not occur; there is a unique extension, which is highly basic in character, to the N-terminus of the capsid protein VP3; and the 2A protein, in common with those of only two other known picornaviruses, is a homologue of a family of cellular proteins involved in the control of cell proliferation. The type member of the Parechovirus genus is a frequent human pathogen, formerly known as echovirus 22, which has been renamed human parechovirus 1. The genus also includes the closely related virus, human parechovirus 2 (formerly echovirus 23). Human parechoviruses generally cause mild, gastrointestinal or respiratory illness, but more serious consequences of infection, such as myocarditis and encephalitis have been reported. Most infections occur in young children. Ljungan virus, a newly identified virus of rodents, shares a number of molecular features with the human parechoviruses, raising important questions about the evolution of parechoviruses and their introduction into the human population.
Most of the small number of cases of poliomyelitis which occur in countries where Sabin's attenuated poliovirus vaccines are used are temporally associated with administration of vaccine and involve polioviruses of types 2 and 3 (ref. 1). Recent studies have provided convincing evidence that the Sabin type 2 and 3 viruses themselves may revert to a neurovirulent phenotype on passage in man. We report here that a point mutation in the 5' noncoding region of the genome of the poliovirus type 3 vaccine consistently reverts to wild type in strains isolated from cases of vaccine-associated poliomyelitis. Virus with this change is rapidly selected on passage through the human gastrointestinal tract. The change is associated with a demonstrable increase in the neurovirulence of the virus.
As part of an investigation into the molecular basis of attenuation in the Sabin poliovirus vaccines, the genomes of three strains of type 3 poliovirus differing in neurovirulence were cloned in Escherichia coli. The nucleotide sequence of the region of the genome encoding the virion protein 1 (VP1) polypeptide from each of these strains is presented. Very few changes were observed, a finding suggesting that the mutation(s) involved in the attenuation of type 3 poliovirus probably lies elsewhere in the genome. The complete nucleotide sequence of one of the strains, P3/Sabin, has been obtained and is compared with the published sequences of type 1 poliovirus. Between serotypes 1 and 3, there is 77% homology in nucleotide sequence and 90% homology in the amino acid sequence predicted for viral proteins.